Atlas Trials

Managing Infliximab Reinduction After Temporary Discontinuation of Drug

Clinical trial NCT02771457 · WITHDRAWN

Trial details

NCT number
NCT02771457
Sponsor
NYU Langone Health
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Inflammatory Bowel Disease
Start date
2016-07-01
Primary completion
2019-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.